Continuous ambulatory peritoneal dialysis (CAPD) in children: a successful case for a bright future in a developing country

Continuous ambulatory peritoneal dialysis (CAPD) in children: a successful case for a bright future in a developing country

Younoussa Keita^1,&, Aliou Abdoulaye Ndongo¹, Cathérine Bebey Engome¹, Ndeye Fatou Sow¹, Ndiogou Seck², Lamine Thiam³, Papa Malick Diouf¹, Ahmed Tall Lemrabott⁴, Idrissa Basse⁵, Abdou Niang⁶, Saoussen Krid⁷, Claude Moreira¹, Remi Salomon⁷, Boucar Diouf⁴, Assane Sylla¹, Ousmane Ndiaye⁸

 

¹Pediatric Unit, Aristide Le Dantec Hospital, Dakar, Sénégal, ²Pediatric Unit, Regional Hospital Centre, Saint Louis, Sénégal, ³Pediatric Unit, Regional Hospital Centre, Ziguinchor, Sénégal, ⁴Nephrology Unit, Aristide Le Dantec Hospital, Dakar, Sénégal, ⁵Pediatric Unit, Diamniadio Hospital, Dakar, Sénégal, ⁶Nephrology Unit, Dalaldiam Hospital, Dakar, Sénégal, ⁷Pediatric unit, Necker Hospital, Paris, France, ⁸Pediatric Unit, Albert Royer’s Children Centre, Dakar, Sénégal

 

 

^&Corresponding author
Younoussa Keita, Pediatric Unit, Aristide Le Dantec Hospital, Dakar, Sénégal,

 

 

 

 

Management of chronic kidney disease remains a challenge in developing countries due to the absence of kidney transplant, limited access to extra-renal purification and the low involvement of health policies particularly for children [1, 2]. PD remains a reliable alternative for renal replacement in pediatrics both in acute and chronic situations. The two PD modalities are represented by continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) with their variants [3-5]. The authors report the first case of successful CAPD in pediatrics in a 13-year-old Senegalese, resident 121km from Dakar.

 

 

This was a 13-year-old boy monitored in the unit since 2017-10-04 for stage V Chronic Kidney Disease (CKD) following a primary nephrotic syndrome by Segmental and Focal Glomerulosclerosis (FSGS) (Figure 1) cortico-resistant and cyclo-resistant since he was 11 years old. The patient was anuric with diuresis at 0.19ml/kg/h. He weighed 32kg and measured 131cm with a normal BMI for his age. He had delayed pubertal development (P1G3). Faced with signs of intolerance in uremia, he first received two successive sessions of haemodialysis then three sessions per week for over 3 months in an adult center. He was switched to CAPD following his parents' choice motivated by a desire to return home situated 121km from Dakar. The TENCKOFF (Figure 2 A, B) catheter was inserted on 2018-03-05 in urology in collaboration with the pediatrics and adult nephrology team. On day 1 after catheter insertion, the peritoneal cavity was rinsed. On day 2 after insertion, the patient had a fever at 39oC, abdominal pain and greenish vomiting. Upon examination, he would scream when his navel is touched. Analysis of the drainage liquid had revealed 650 leucocytes/mm³ with 62% of neutrophils. The dialysate culture was sterile. The hemoculture came back negative. The nasal swab isolated Staphylococcus aureus. The patient received 1g of C3G in each bag of 2L of dialysate associated with a bacitracin+neomycine nasal rub as from day 2 after catheter insertion. The plan proposed to the patient was 4 swabs a day (8am - 12noon - 4pm - 8pm - 8am) with a stasis of isotonic dialysate of 4 hours per session during the day and a stasis of icodextrin for 8 hours at night. The total time for dialysis was 24 h/day and the volume of injection per cycle was 1L of dialysate. The peritoneal control fluid at day 7 was sterile (leucocytes 21 elements/mm³ with 95% lymphocytes). The antibiotic treatment was done by oral route for 14 days. Besides the PD, the patient was receiving anti-hypertensive treatment, water restriction, active calcium and vitamin D supplementation, erythropoietin and a CKD diet. After the infection period, an equilibration Test (PET test) revealed a Hyper-permeable peritoneal membrane with D/P creatinine at 0.91. The patient and his mother were trained and assessed on the PD technique (Figure 2 C). By the end of a month, they had become independent and could recognize the signs or dysfunction of the catheter. Patient assessment during this first month of dialysis revealed an adequate clinical and biological condition (Table 1). The patient and his mother returned home at Bambey, a town situated 121km from Dakar with a tracking sheet in which the weight, blood pressure, temperature and ultra filtrate are noted. After a second month of observation, the patient complained of abdominal pain at the day hospital. The plain abdominal X-ray revealed a catheter migration to the right (Figure 2 D). The catheter was repositioned in the patient through the use of laxatives. After 4 months of observation, the dialysis was considered adequate on a clinical and biological basis (Table 1).

 

 

Peritoneal dialysis remains the chronic kidney disease dialysis replacement therapy at this dialysis stage in children in this context. It is a back-up solution in children with ESRD though with significant constraints [6, 7]. Even though kidney transplant is the preferred treatment method for patients suffering from CKD, most patients are placed on dialysis while waiting for transplant or as the only treatment [3]. The patient went in for CAPD, which, in this context, was the only method left for the child to be able to return home with the family. Clinically, the plan prescribed helped with significant regression of the edematous-ascitic syndrome with weight loss, positive ultra filtration and blood pressure control with a Cardiothoracic Index at 0.53. According to the authors, the short stasis during the day facilitated ultra filtration while the night stasis of icodextrin facilitated purification [8]. The challenge of dialysis adequacy in this patient also laid on the fact that residual diuresis was practically nil. In fact, only residual renal function and peritoneal ultra filtration (UF) maintainers in anuric patients were correlated to the survival of patients and considered as major predictive factors of cardiovascular morbidity and mortality [9, 10]. These two factors then became essential parameters for adequacy. The management of anaemia was one of the difficulties faced with the patient due to the expensive cost of erythropoietin even if consumption is less in PD than in hemodialysis [11]. Moreover, calcium phosphate metabolism control plays a significant role in PD adequacy and especially glycemic load control considered as the cornerstone in PD patients [9]. The patient had normoglycemia and a satisfactory nutritional status. The authors explain that among other factors, a good nutritional status was also very essential for PD adequacy [12-14]. Nutritional, social and psycho-emotional support was proposed to the child and his family especially through the social worker of the unit.

 

Among the PD complications, dialysis fluid infection is the most common, first reason why the technique can be stopped with an average period of 20 to 30 months-patient [15]. In this context of a developing country, prevention of peritoneal liquid infections is our bedrock. Strict asepsis, prophylactic antibiotic therapy during catheter insertion and education of care givers and the patient will minimise the risk of peritonitis. Despite a hyper-permeable dialysis membrane after the infectious period, the dialysis plan did not change. In fact, the dialysis at this moment was adequate. This hyper-permeability could be explained by the recent dialysis fluid infection. According to the authors, the peritoneal equilibration test (PET test) should be done during observation of the patient, in case of inadequacy and far from the peritonitis periods. After the infection, the child had a catheter migration two months after the onset of PD. The authors mentioned in the literature that complications related to PD catheter displacement occur late and are associated with abdominal pain [4]. In this patient, the catheter was repositioned by taking a laxative. After 4 months of observation, the patient and his mother were still independent with CAPD which helped solved the problem of lodging this family in Dakar. Ever since, the patient was staying at home with his family 121km from Dakar. He narrated his story during several cultural events both at the family and social level. He will be able to return to school next academic year in the month of October. These elements sum up the many advantages of this technique in this patient amongst others as mentioned in the literature [16]. For a better future, kidney transplant authorised in Senegal since 2015 would be the ideal treatment for this boy.

 

 

The authors report on their first successful CAPD experience in children in Sénégal. This technique helped to stabilise the patient. Satisfaction in this case laid on the one hand in overcoming the constraints linked to chronic hemodialysis and on the other hand in the return of this child to his family. Although this method of extra renal purification was effective, it is important to underline that much remains to be done to prevent the risk of infection and to popularise PD in this context of a developing country. For the future of this patient, a kidney transplant would be the best therapy.

 

 

The authors declare no competing interests.

 

 

Younoussa Keita, Aliou Abdoulaye Ndongo, Catherine Bebey, Ndiogou Seck, Ndeye Fatou Sow, Papa Malick Diouf, Lamine Thiam, Ahmed Tall Lemrabott, Idrissa Basse took care of the child and wrote the article. Abdou Niang, Saoussen Krid, Claude Moreira, Remi Salomon, Boucar Diouf, Assane Sylla A, Ousmane Ndiaye did the proofreading, correction and validation of the article.

 

 

The authors send their thanks to Prof. Boucar Diouf, Head of Nephrology Department (Dakar), Prof. Abdou Niang, Nephrologist (Dakar), Dr. Saoussen Krid & Prof.Rémi Salomon, Pediatric Nephrologists at Necker (Paris, France), International Society of Nephrology (ISN) and the entire pediatric team at Aristide Le Dantec Hospital.

 

 

Table 1: evolution of monitoring parameters for dialysis adequacy

Figure 1: focal and segmental glomerulosclerosis (FSGS): fibrohyaline segmental glomerular lesions surrounded by dysmorphic podocytes Masson’s trichrome x 250

Figure 2: A) surgical insertion of TENCKOFF catheter; B) control ASP showing the catheter in a good position in the pouch of Douglas; C) the patient and his mother after the drainage; D) catheter migration in the right lumbar region

 

 

1. Cochat P, Cazet F, Liutkus A, Mourani C, Exantus J, Akatcherian C. Néphrologie pédiatrique dans les pays en développement. Arch Pediatr. 2005; 12(6): 723-725. PubMed | Google Scholar


2. Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Averting the legacy of kidney disease - focus on childhood. Afr J Prm Health Care Fam Med. 2016; 8(1): 1-5. PubMed | Google Scholar


3. Fenton SS, Schaubel DE, Desmeules M et al. Hémodialyse versus dialyse péritonéale: comparaison des taux de mortalité ajustés. Am J Kidney Dis. 1997; 30(3): 334-342.


4. Ryckelynck JP, Lobbedez T, Hurault de Ligny B. Dialyse péritonéale. Nephro Ther. 2005; 1(4): 252-263. Google Scholar


5. Leonard MB, Donaldson IA, Ho M. A prospective cohort study of incident maintenance dialysis in children: An NAPRTC study. Kidney Int. 2003; 63(2): 744-75. PubMed | Google Scholar


6. Belkacemi L, Bousbaa Z, Haddoum F. Dialyse péritonéale chez l'enfant en IRCT: expérience du service de néphrologie du CHU Nefissa Hamoud, Ex Parnet, Hussein-Dey, Alger. Nephrol Ther. 2014; 10(6): 301-302. Google Scholar


7. Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA et al. Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4D): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018; 93(6): 1281-1292. PubMed | Google Scholar


8. Fischbach M, Zaloszyc A, Schaefer B et al. Optimisation de la prescription de dialyse péritonéale pour le contrôle du volume: l'importance de varier le temps de stase et le volume de stase. Pediatr Nephrol. 2014; 29(8): 1321-1327.


9. Brown EA1 Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD outcome Study. Jam SocNephrol. 2003; 14(11): 2948-2957. PubMed | Google Scholar


10. Anna T Mathew, Fishbane S, Obi Y, Kalantar-Zadeh K. Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int. 2016; 90(2): 262-271. PubMed | Google Scholar


11. Chanliau J, Kessler M. Peritoneal dialysis in the management of kidney disease: financial, nephrologic and therapeutic aspects. Nephrol Ther. 2011; 7(1): 32-37.


12. Belkacem I, Pierre-Yves D, Pascale S, Joëlle Cridlig, Guillaume Jean et al. Adéquation en dialyse péritonéale: mise au point. Nephrol Ther. 2013; 9(6): 416-425. Google Scholar


13. Fischbach M, Schmitt CP, Shroff R, Zaloszyc A, Warady BA. Increasing sodium removal on peritoneal dialysis: applying dialysis mechanics to the peritoneal dialysis prescription. Kidney Int. 2016; 89(4): 761-766. PubMed | Google Scholar


14. Aufricht C, Beelen R, Eberl M, Fischbach M, Fraser D, Jörres A et al. Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network. Kidney Int. 2017; 92(4): 824-835. PubMed | Google Scholar


15. Piraino B. Peritonitis as a complication of peritoneal dialysis. J Am SocNephrol. 1998; 9(10): 1956-1964. PubMed | Google Scholar


16. Ryckelynck JP, Lobbedez T, Hurault de Ligny B. Dialyse péritonéale. Nephrol Ther. 2005; 1(4): 252-263. Google Scholar